pyrazolanthrone has been researched along with carnitine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Li, H; Li, M; Liao, X; Wang, F; Yang, S; Zhao, C | 1 |
2 other study(ies) available for pyrazolanthrone and carnitine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
L‑carnitine attenuates TGF‑β1‑induced EMT in retinal pigment epithelial cells via a PPARγ‑dependent mechanism.
Topics: Anilides; Anthracenes; Butadienes; Carnitine; Cell Movement; Cells, Cultured; Epithelial Cells; Epithelial-Mesenchymal Transition; Humans; MAP Kinase Signaling System; Models, Biological; NF-kappa B; Nitriles; PPAR gamma; Retinal Pigment Epithelium; Smad Proteins; Transforming Growth Factor beta1 | 2021 |